Early patient data from Phase 2b clinical trial showed significant and selective tumor uptake in brain metastases compared to ...
Theranostics announced that the Phase 2b trial evaluating RAD101 imaging in brain metastases has achieved 50% patient enrollment ...
6d
ZAP Surgical's ZAP-Axon Radiosurgery Planning System Receives U.S. FDA 510(k) and E.U. CE Clearance
ZAP Surgical Systems, Inc., a pioneer in non-invasive robotic brain surgery, today announced that its award-winning ZAP-Axon(R) Radiosurgery Planning System has received both U.S. FDA 510(k) clearance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback